Narcotic Drugs and Psychotropic Substances Act, 1985 | |
---|---|
Parliament of India | |
| |
Citation | Act No. 61 of 1985 |
Territorial extent | India |
Assented to | 16 September 1985 |
Commenced | 14 November 1985 |
Legislative history | |
Bill title | The Narcotic Drugs and Psychotropic Substances Bill, 1985 |
Introduced | 23 August 1985 |
Amended by | |
1988, 2001, 2014 and 2021 | |
Related legislation | |
Prevention of Illicit Trafficking in Narcotic Drugs and Psychotropic Substances Act, 1988 | |
Status: Amended |
The Narcotic Drugs and Psychotropic Substances Act, 1985, commonly referred to as the NDPS Act, is an Act of the Parliament of India that prohibits the production/manufacturing/cultivation, possession, sale, purchase, transport, storage, and/or consumption of any narcotic drug or psychotropic substance. The bill was introduced in the Lok Sabha on 23 August 1985. It was passed by both the Houses of Parliament, received assent from then President Giani Zail Singh on 16 September 1985, and came into force on 14 November 1985. The NDPS Act has since been amended four times — in 1988, 2001, 2014 and 2021. The Act extends to the whole of India and applies also to all Indian citizens outside India and to all persons on ships and aircraft registered in India.
The Narcotics Control Bureau was set up under the act with effect from March 1986. The Act is designed to fulfill India's treaty obligations under the Single Convention on Narcotic Drugs, Convention on Psychotropic Substances, and United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances.There are 6 Chapters and 83 Sections in NDPS act 1985.
India had no legislation regarding narcotics until 1985. Cannabis smoking in India has been known since at least 2000 BC [1] and is first mentioned in the Atharvaveda, which dates back a few thousands years BC. [2] The Indian Hemp Drugs Commission, an Indo-British study of cannabis usage in India appointed in 1893, found that the "moderate" use of hemp drugs was "practically attended by no evil results at all", "produces no injurious effects on the mind" and "no moral injury whatever". Regarding "excessive" use of the drug, the Commission concluded that it "may certainly be accepted as very injurious, though it must be admitted that in many excessive consumers the injury is not clearly marked". The report the Commission produced was at least 3,281 pages long, with testimony from almost 1,200 "doctors, coolies, yogis, fakirs, heads of lunatic asylums, bhang peasants, tax gatherers, smugglers, army officers, hemp dealers, ganja palace operators and the clergy." [3] [4]
Cannabis and its derivatives (marijuana, hashish/charas and bhang) were legally sold in India until 1985, and their recreational use was commonplace. Consumption of cannabis was not seen as socially deviant behaviour, and was viewed as being similar to the consumption of alcohol. Ganja and charas were considered by upper class Indians as the poor man's intoxicant, although the rich consumed bhang during Holi. The United States began to campaign for a worldwide law against all drugs, following the adoption of the Single Convention on Narcotic Drugs in 1961. However, India opposed the move, and withstood American pressure to make cannabis illegal for nearly 25 years. American pressure increased in the 1980s, and in 1985, the Rajiv Gandhi government succumbed and enacted the NDPS Act, banning all narcotic drugs in India.
Anyone who contravenes the NDPS Act will face punishment based on the quantity of the banned substance.
The table below lists the current definition of a small quantity and a commercial quantity for some popular drugs. [7]
Drug | Small quantity | Commercial quantity |
---|---|---|
Amphetamine | 2 grams (0.071 oz) | 50 grams (1.8 oz) |
Charas | 100 grams (3.5 oz) | 1 kilogram (2.2 lb) |
Cocaine | 2 grams (0.071 oz) | 100 grams (3.5 oz) |
Ganja(Marijuana) | 1 kilogram (2.2 lb) | 20 kilograms (44 lb) |
Heroin | 5 grams (0.18 oz) | 250 grams (8.8 oz) |
LSD | 2 milligrams (0.031 gr) | 100 milligrams (1.5 gr) |
Methadone | 2 grams (0.071 oz) | 50 grams (1.8 oz) |
Morphine | 5 grams (0.18 oz) | 250 grams (8.8 oz) |
Opium | 25 grams (0.88 oz) | 2.5 kilograms (5.5 lb) |
Critics of the NDPS Act say that the restriction that the act is "draconian" and that it imposes on the grant of bail amount to "amount to virtual denial and ensure years of incarceration". Critics say that the conditions of bail under this act are needlessly harsh and are similar to provisions of the Terrorist and Disruptive Activities (Prevention) Act, 1987 and Prevention of Terrorism Act, 2002 which result in long periods of imprisonment and that the NDPS act places the burden-of-proof entirely on the accused to establish innocence. [8] Furthermore, some critics point out that under this act, there is a presumption of "culpable mental state", that is, the court will presume that there was an intention to commit a crime. They claim that this goes against the general principle of the law where people accused of a crime are assumed to be innocent until proven guilty. [9]
There is a higher threshold for bail in serious cases under the Act. Under Section 37 of the NDPS Act, if a person is accused of an offence involving "commercial quantities", that is, more than 1 kg in case of hashish, and serious offences such as financing illicit traffic and harbouring offenders, then bail can only be granted if "the court is satisfied that there are reasonable grounds for believing that he is not guilty of such offence and that he is not likely to commit any offence while on bail".
During the discussion of the Bill in Parliament, several members opposed it for treating hard and soft drugs as the same. However, the Rajiv Gandhi administration claimed that soft drugs were gateway drugs. [10]
The NDPS Act was criticized in The Times of India . The paper described the law as "ill-conceived" and "poorly thought-out" due to the law providing the same punishment for all drugs, which meant that dealers shifted their focus to harder drugs, where profits are far higher. The paper also argued that the Act had "actually created a drugs problem where there was none." The Times of India recommended that some of the softer drugs should be legalized, as this might reduce the level of heroin addiction. [11]
In 2015, Lok Sabha MP Tathagata Satpathy criticized the ban on cannabis as "elitist", and labeling cannabis the "intoxicant" of the poor. He also felt that the ban was "an overreaction to a scare created by the United States". Sathpathy has also advocated the legalisation of cannabis. [12] [13] [14] On 2 November 2015, Lok Sabha MP Dharamvir Gandhi announced that he had received clearance from Parliament to table a Private Member's Bill seeking to amend the NDPS Act to allow for the legalised, regulated, and medically supervised supply of "non-synthetic" intoxicants including cannabis and opium. [15]
In November 2016, former commissioner of the Central Bureau of Narcotics Romesh Bhattacharji said of the law, "This needs to be debated in the face of such stiff ignorance which often takes root in the moral high grounds people take after being influenced by the UN conventions. This law [NDPS Act] has been victimising people since 1985". [16]
The Narcotic Drugs and Psychotropic Substances (Amendment) Act, 1988 (Act No. 2 of 1989) received assent from then President Ramaswamy Venkataraman on 8 January 1989. [17]
The Narcotic Drugs and Psychotropic Substances (Amendment) Act, 2001 (Act No. 9 of 2001) received assent from then President K. R. Narayanan on 9 May 2001. [18] [19]
The Narcotic Drugs and Psychotropic Substances (Amendment) Act, 2014 (Act No. 16 of 2014) amended the NDPS Act to relax restrictions placed by the Act on Essential Narcotic Drugs (Morphine, Fentanyl and Methadone), making them more accessible for use in pain relief and palliative care. [20] [21] The Amendment also contained measures to improve treatment and care for people dependent on drugs, opened up the processing of opium and concentrated poppy straw to the private sector, and strengthened provisions related to the forfeiture of property of persons arraigned on charges of drug trafficking. The Amendment also removed the NDPS Act's imposition of a mandatory death sentence in case of a repeat conviction for trafficking large quantities of drugs, giving courts the discretion to use the alternative sentence of 30 years imprisonment for repeat offences. However, the Amendment increased the punishment for "small quantity" offences from a maximum of 6 months to 1 year imprisonment. [22]
The Narcotic Drugs and Psychotropic Substances (Amendment) Bill, 2011 (Bill No. 78 of 2011) was introduced in the Lok Sabha on 8 September 2011 by then Minister of Finance Pranab Mukherjee. The Bill was referred to the Standing Committee on Finance, chaired by Yashwant Sinha, on 13 September. The committee was scheduled to submit its report within three months, but actually submitted it on 21 March 2012. The Bill was passed by the Lok Sabha on 20 February 2014, and by the Rajya Sabha the next day. [23] It received the assent of then President Pranab Mukherjee on 7 March 2014, and was published in The Gazette of India on 10 March. [24] [25]
Currently, under Section 27 of the NDPS Act, possession of small quantities for personal consumption of drugs is a punishable offence, and can attract a fine of ₹10,000 and imprisonment of six months or both. [26] The Union Ministry of Social Justice and Empowerment has recommended decriminalizing of possession of small quantities of drugs for personal use. The ministry suggested that the NDPS Act be amended to treat the consumer of drugs as victims who ought to be referred for rehabilitation and de-addiction, and not as criminals to be sentenced to jail. [27]
On 10 November 2021, a high-level meeting of all key stakeholders was held where a consensus was reached to do away with imprisonment and fines for personal consumption of drugs and amend Section 27 of the NDPS Act, and the possibility of rehabilitation and deaddiction programs of 30 days for drug users was discussed. [26] The proposal under discussion sought to replace the word "consumption" with "other than personal consumption (in small quantity)" and also sought to replace the word "addict" with "person with substance use disorder". The reason for this change was to help the courts take a more lenient view on people caught with small quantities, and to more strongly emphasize the difference between possession of drugs for personal consumption and possession of drugs for commercial use. Advocates of the proposal state that drug decriminalization is an important step towards achieving a rational drug policy that puts science and public health before punishment and incarceration. The proposal also suggests that mandatory treatment for de-addiction for 30 days for any person who has been found to have consumed or be in possession to consume drugs. [28]
The prohibition of drugs through sumptuary legislation or religious law is a common means of attempting to prevent the recreational use of certain intoxicating substances.
Bhang is an edible preparation made from the leaves of the cannabis plant originating from the Indian subcontinent. It has been used in food and drink as early as 1000 BC in ancient India. Bhang is traditionally distributed during the spring festival of Maha Shivaratri and Holi. Bhang is mainly used in bhang shops, which sell the cannabis-infused Indian drinks bhang lassi and bhang thandai.
Charas is a cannabis concentrate made from the resin of a live cannabis plant and is handmade in the Indian subcontinent. The plant grows wild throughout Northern India along the stretch of the Himalayas and is an important cash crop for the local people. The difference between charas and hashish is that hashish is made from a dead cannabis plant and charas is made from a live one.
The Single Convention on Narcotic Drugs, 1961 is a United Nations treaty that controls activities of specific narcotic drugs and lays down a system of regulations for their medical and scientific uses; it also establishes the International Narcotics Control Board.
The United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988 is one of three major drug control treaties currently in force. It provides additional legal mechanisms for enforcing the 1961 Single Convention on Narcotic Drugs and the 1971 Convention on Psychotropic Substances. The Convention entered into force on November 11, 1990. As of June 2020, there are 191 Parties to the Convention. These include 186 out of 193 United Nations member states and the Holy See, the European Union, the Cook Islands, Niue, and the State of Palestine.
The Misuse of Drugs Act 1975 is a New Zealand drug control law that classifies drugs into three classes, or schedules, purportedly based on their projected risk of serious harm. However, in reality, classification of drugs outside of passing laws, where the restriction has no legal power, is performed by the governor-general in conjunction with the Minister of Health, neither of whom is actually bound by law to obey this restriction.
The Narcotic Control Act, passed in 1961, was one of Canada's national drug control statutes prior to its repeal by the 1996 Controlled Drugs and Substances Act. It implemented the provisions of the Single Convention on Narcotic Drugs.
Tathagata Satpathy was a member of the 12th, 14th, 15th and 16th Lok Sabha of India. He represented the Dhenkanal constituency of Odisha, and was re-elected for the fourth time in 2014. He was a member of the Biju Janata Dal (BJD) political party, and the party's chief whip in the Lok Sabha. He took voluntary retirement from politics in March 2019. He is not an active politician ever since.
A drug policy is the policy regarding the control and regulation of psychoactive substances, particularly those that are addictive or cause physical and mental dependence. While drug policies are generally implemented by governments, entities at all levels may have specific policies related to drugs.
Drug liberalization is a drug policy process of decriminalizing, legalizing, or repealing laws that prohibit the production, possession, sale, or use of prohibited drugs. Variations of drug liberalization include drug legalization, drug relegalization, and drug decriminalization. Proponents of drug liberalization may favor a regulatory regime for the production, marketing, and distribution of some or all currently illegal drugs in a manner analogous to that for alcohol, caffeine and tobacco.
Cannabis in Switzerland is illegal, though minor possession was decriminalised to a fine in 2012. Several cantons began to allow adults to cultivate and use cannabis in 2012, but this was struck down by federal courts. In 2016, four cities stated they were looking into establishing pilot cannabis clubs. The number of cannabis users in Switzerland is estimated to be around 500,000 among a population of 8 million.
Canada's drug regulations are measures of the Food and Drug Act and the Controlled Drugs and Substances Act. In relation to controlled and restricted drug products, the Controlled Drugs and Substances Act establishes eight schedules of drugs and new penalties for the possession, trafficking, exportation and production of controlled substances as defined by the Governor-in-Council. Drug policy of Canada has traditionally favoured punishment for the smallest of offences, but this convention was partially broken in 1996 with the passing of the Controlled Drugs and Substances Act.
Cannabis is a plant used in Australia for recreational, medicinal and industrial purposes. In 2022–23, 41% of Australians over the age of fourteen years had used cannabis in their lifetime and 11.5% had used cannabis in the last 12 months.
The major drug laws of India are the Narcotic Drugs and Psychotropic Substances Act (1985) and the Prevention of Illicit Trafficking in Narcotic Drugs and Psychotropic Substances Act (1988).
Juvenile Justice Act, 2015 has been passed by Parliament of India amidst intense controversy, debate, and protest on many of its provisions by Child Rights fraternity. It replaced the Indian juvenile delinquency law, Juvenile Justice Act, 2000, and allows for juveniles in conflict with Law in the age group of 16–18, involved in Heinous Offences, to be tried as adults. The Act also sought to create a universally accessible adoption law for India, overtaking the Hindu Adoptions and Maintenance Act (1956) and the Guardians and Wards Act (1890), though not replacing them. The Act came into force from 15 January 2016.
Cannabis in India has been known to be used at least as early as 2000 BCE. In Indian society, common terms for cannabis preparations include charas (resin), ganja (flower), and bhang, with Indian drinks such as bhang lassi and bhang thandai made from bhang being one of the most common legal uses.
Cannabis in Latvia is illegal for recreational and medical purposes, but production of industrial hemp is permitted.
Cannabis in Slovakia is illegal for all purposes and possession of even small amounts of the drug can lead to lengthy prison terms. Possession or use of small amounts of cannabis is punishable by up to eight years in prison. In April 2012, The Wall Street Journal reported that Robert Fico, the incoming Slovak prime minister, might push for partial legalisation of cannabis possession, and has argued for the legalisation of possession of up to three doses of cannabis for personal use.
The Great Legalisation Movement India is a non-profit organisation working to legalise the use of cannabis for medical and industrial purposes in India. It was founded in November 2014 by Viki Vaurora. The social stigma associated with cannabis has long been prevalent among many communities in India. The campaign aims to educate people on the history and uses of cannabis and pave way for its legalisation to initiate a nationwide green industrial setup replacing thousands of ecologically damaging products with sustainable hemp-based alternatives.
The Cannabis Act (C-45) of June, 2018 paved the way for the legalization of cannabis in Canada on 17 October 2018. Police and prosecution services in all Canadian jurisdictions are currently capable of pursuing criminal charges for cannabis marketing without a licence issued by Health Canada. The Supreme Court of Canada has held that the federal Parliament has the power to criminalize the possession of cannabis and that doing so does not infringe upon the Canadian Charter of Rights and Freedoms. The Ontario Court of Appeal and the Superior Court of Ontario have, however, held that the absence of a statutory provision for medical marijuana is unconstitutional, and to that extent the federal law is of no force and/or effect if a prescription is obtained. The recreational use of cannabis has been legalized by the federal government, and took effect on 17 October 2018.
{{cite web}}
: CS1 maint: archived copy as title (link){{cite web}}
: CS1 maint: archived copy as title (link){{cite web}}
: CS1 maint: archived copy as title (link)